An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults (Q30414122)

20 February 2018

title

An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults (English)

1 reference

20 February 2018

4

François Roman

1 reference

20 February 2018

Paul Gillard

1

object named as

Paul Gillard

1 reference

20 February 2018

Mamadou Dramé

7

object named as

Mamadou Dramé

1 reference

20 February 2018

author name string

Adrian Caplanusi

2

1 reference

20 February 2018

Markus Knuf

3

1 reference

20 February 2018

Karl Walravens

5

1 reference

20 February 2018

Philippe Moris

6

1 reference

20 February 2018

Tino F Schwarz

8

1 reference

20 February 2018

language of work or name

1 reference

9 March 2012

1 reference

20 February 2018

Influenza and Other Respiratory Viruses

published in

1 reference

20 February 2018

volume

7

1 reference

20 February 2018

issue

1

1 reference

20 February 2018

page(s)

55-65

1 reference

20 February 2018

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Vaccine adjuvants alter TCR-based selection thresholds.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Update on avian influenza A (H5N1) virus infection in humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1750-2659.2012.00349.X

Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5780732

Development of vaccines against influenza H5

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22405557

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1750-2659.2012.00349.X

1 reference

20 February 2018

PMC publication ID

5780732

1 reference

20 February 2018

PubMed publication ID

22405557

1 reference

20 February 2018